Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1-positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study. 31247675 2019
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 AlteredExpression disease BEFREE Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study. 30251205 2019
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction. 31533028 2019
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 29472719 2018
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML. 28538183 2017
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. 27851970 2016
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 AlteredExpression disease BEFREE Macrocalyxin A inhibits proliferation and induces apoptosis of t (8;21) leukemia cells through mitochondrial signaling pathways and regulates AML-ETO mRNA expression. 26016618 2015
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells. 25928846 2015
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE PML-RARA and AML1-ETO are important oncogenic fusion proteins that play a central role in transformation to acute myeloid leukemia (AML). 24449212 2014
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 GeneticVariation disease BEFREE Co-transduction of Kras(G12D) and AML1/ETO induces acute monoblastic leukemia. 24480914 2014
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE In this review, we discuss the pathogenetic insights that have been gained from identifying the various events that can cooperate with AML1-ETO to induce AML in vivo. 22875638 2012
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 AlteredExpression disease BEFREE To determine whether GM-CSF signaling affects RUNX1-ETO leukemogenesis, hematopoietic stem/progenitor cells that lack GM-CSF signaling were used to express RUNX1-ETO and transplanted into lethally irradiated mice, and a high penetrance of AML was observed in recipients. 22223820 2012
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. 22343733 2012
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE These findings establish AES as a novel AML1/ETO-induced target gene that plays an important role in the self-renewal phenotype of t(8;21)-positive AML. 21245488 2011
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse. 19891700 2010
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2. 18206543 2008
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. 18258796 2008
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors. 17377588 2007
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 GeneticVariation disease BEFREE KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival. 16254134 2006
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 AlteredExpression disease BEFREE siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts. 16652140 2006
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 AlteredExpression disease BEFREE The chromosomal translocation t(8;21), generating the AML1-ETO fusion protein, is frequently associated with French-American-British (FAB) type M2 acute myeloid leukemia (AML). t(8;21) fuses the runt domain from the hematopoietic transcription factor RUNX1 with almost the entire transcriptional repressor ETO. 16390317 2005
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. 14551142 2004
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE RUNX1-ETO) fusion protein, which is found in t(8;21)+ AML. 15156180 2004
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 Biomarker disease BEFREE The morphologic finding of bone marrow in AML-M2 showed higher incidence of Auer rods, large blast with prominent golgi and abnormal granules in AML1/ETO positive patients. 12760263 2003
Entrez Id: 862
Gene Symbol: RUNX1T1
RUNX1T1
0.100 GeneticVariation disease BEFREE Following the development of therapy-related leukemia after 1 year, evolution of therapy-related AML-M4 with t(11;17)(q23;q25) and the rearrangement of the MLL gene were observed, while AML/MTG8 disappeared. 10905055 2000